LumiraDx Investor Presentation Deck
Number of LumiraDx Instruments within Health System
Use cases
POL
Urgent care
Pharmacy
Hospital lab
Reference lab
Surgery
West Coast Health System:
Small Start, Big Finish
lumiraDx™
125
Q3 2021
158
Q4 2021
402
Q1 2022
422
Q2 2022
Case Study
Multiple COVID testing solutions established early in the
pandemic
High interest in LumiraDx microfluidic technology led to
initial partnership
Initial Physician Office focused program expanded to
replace all existing POC molecular systems
• Performance comparable to POC molecular system
Ⓒ San Diego R&D visit strengthened interest in future
pipeline
• Manufacturing and supply capabilities in Q4 to provide
uninterrupted supply
Copyright © 2022 Lumirax Ltd. All Rights Reserved, Worldwide
"Grateful for the support and partnership,
LumiraDx agility has been great"
Director of Sourcing Laboratory Services
46View entire presentation